5X5O

Crystal structure of ZAK in complex with compound D2829

  • Classification: TRANSFERASE
  • Organism(s): Homo sapiens
  • Expression System: Spodoptera frugiperda
  • Mutation(s): No 

  • Deposited: 2017-02-17 Released: 2017-12-27 
  • Deposition Author(s): Dai, Y.B., Zhao, P., Yun, C.H.
  • Funding Organization(s): National Science Foundation of China, National Basic Research Program of China, Ministry of Science and Technology of China

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.87 Å
  • R-Value Free: 0.226 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.192 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-alpha Motif Kinase (ZAK) Inhibitors.

Chang, Y.Lu, X.Shibu, M.A.Dai, Y.B.Luo, J.Zhang, Y.Li, Y.Zhao, P.Zhang, Z.Xu, Y.Tu, Z.C.Zhang, Q.W.Yun, C.H.Huang, C.Y.Ding, K.

(2017) J Med Chem 60: 5927-5932

  • DOI: https://doi.org/10.1021/acs.jmedchem.7b00572
  • Primary Citation of Related Structures:  
    5X5O

  • PubMed Abstract: 

    A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class of highly selective ZAK inhibitors. The representative compound 3h strongly inhibits the kinase activity of ZAK with an IC 50 of 3.3 nM and dose-dependently suppresses the activation of ZAK downstream signals in vitro and in vivo, while it is significantly less potent for the majority of 403 nonmutated kinases evaluated. Compound 3h also exhibits orally therapeutic effects on cardiac hypertrophy in a spontaneous hypertensive rat model.


  • Organizational Affiliation

    State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macao, China.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Mitogen-activated protein kinase kinase kinase MLT310Homo sapiensMutation(s): 0 
Gene Names: ZAKMLTKHCCS4
EC: 2.7.11.25
UniProt & NIH Common Fund Data Resources
Find proteins for Q9NYL2 (Homo sapiens)
Explore Q9NYL2 
Go to UniProtKB:  Q9NYL2
PHAROS:  Q9NYL2
GTEx:  ENSG00000091436 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9NYL2
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
7Z0
Query on 7Z0

Download Ideal Coordinates CCD File 
B [auth A]N-[2,4-bis(fluoranyl)-3-[2-(3-methoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]phenyl]-3-bromanyl-benzenesulfonamide
C21 H13 Br F2 N4 O3 S
PJGQKTLXZJMPIM-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
7Z0 BindingDB:  5X5O IC50: 5 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.87 Å
  • R-Value Free: 0.226 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.192 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 131.057α = 90
b = 48.501β = 105.48
c = 42.625γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data reduction
HKL-3000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Science Foundation of ChinaChina31270769
National Basic Research Program of ChinaChina2012CB917202
Ministry of Science and Technology of ChinaChinaNCET-12-0013

Revision History  (Full details and data files)

  • Version 1.0: 2017-12-27
    Type: Initial release
  • Version 1.1: 2024-03-27
    Changes: Data collection, Database references